Lv3
220 积分 2024-04-20 加入
A patent review on HMGB1 inhibitors for the treatment of liver diseases
15小时前
待确认
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
16小时前
已完结
N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling study
16小时前
已完结
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
17小时前
已完结
Ecliptasaponin A protects heart against acute ischemia-induced myocardial injury by inhibition of the HMGB1/TLR4/NF-κB pathway
10个月前
已完结
Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy
1年前
已完结
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
1年前
已完结
HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation
1年前
已完结
Association between high-mobility group box 1 levels and preeclampsia: a systematic review and meta-analysis
1年前
已完结
Therapeutic effects of anti-diabetic drugs on traumatic brain injury
1年前
已完结
皖公网安备34019202002308
